"10.1371_journal.pone.0072642","plos one","2013-09-02T00:00:00Z","Suzanne M Lloyd; David J Stott; Anton J M de Craen; Patricia M Kearney; Naveed Sattar; Ivan Perry; Christopher J Packard; Andrew Briggs; Laura Marchbank; Harry Comber; J Wouter Jukema; Rudi G J Westendorp; Stella Trompet; Brendan M Buckley; Ian Ford","Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom; Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands; Department of Epidemiology and Public Health, University College, Cork, Ireland; National Health Service Research and Development Directorate, Greater Glasgow and Clyde Health Board, Glasgow, United Kingdom; Health Economics and Health Technology Assessment, University of Glasgow, Glasgow, United Kingdom; Information Services Division Scotland, National Health Service (Scotland), Paisley, United Kingdom; National Cancer Registry, Cork, Ireland; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; Department of Pharmacology and Therapeutics, University College, Cork, Ireland","Conceived and designed the experiments: DJS NS CJP AB JWJ RGJW BMB IF. Performed the experiments: DJS AJMdC PMK NS IP LM HC JWJ RGJW ST BMB. Analyzed the data: SML IF. Wrote the paper: SML DJS AJMdC PMK NS IP CJP AB LM HC JWJ RGJW ST BMB IF.","The authors have read the journals policy and have the following conflicts: DS has received funding/support from Bristol-Myers Squibb, Astra Zeneca, Merck Serono and Fresenius, honoraria/consultancy from Bristol-Myers Squibb, Astra Zeneca and Nutricia and support for conference attendance from Bristol Myers-Squibb and Nutricia. JJ has received grants from and was a speaker on (CME accredited) meetings sponsored by Astellas, Astra Zeneca, Bayer, Biotronik, Boston Scientific, Daiichi Sankyo, Lilly, Genzyme, Merck-Shering-Plough, Pfizer, Orbus Neich, Novartis, Roche, Servier, Sanofi Aventis, the Netherlands Heart Foundation, the Interuniversity Cardiology Institute of the Netherlands, and the European Community Framework KP7 Programme. IF has received research funding from Pfizer. All other authors do not report any conflicts of interest. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Suzanne M Lloyd","SML",15,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
